Focuses on improving the diagnosis and characterization of common and uncommon causes of dementia, including neurodegenerative and autoimmune-mediated brain diseases.

Integrates clinical assessment with structural and functional neuroimaging and biofluid biomarkers to clarify disease mechanisms, guide treatment, and improve long-term outcomes.